Skip to main content
Signal8
Boctor Fady profile photo

Fady Boctor

CIK: 0001833394

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Petros Pharmaceuticals, Inc. logo
PTPI

Petros Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Petros Pharmaceuticals, Inc. logo
    PTPI

    Petros Pharmaceuticals, Inc.

    Jun 5, 2026
    Award(A)
    Direct
    375K shares-
  • Petros Pharmaceuticals, Inc. logo
    PTPI

    Petros Pharmaceuticals, Inc.

    Jan 2, 2026
    Award(A)
    Direct
    500K shares-
  • Petros Pharmaceuticals, Inc. logo
    PTPI

    Petros Pharmaceuticals, Inc.

    Feb 19, 2025
    Award(A)
    Direct
    450K shares-

1-3 of 3

About Boctor Fady

Boctor Fady (SEC CIK 0001833394) files insider reports with the SEC as Officer of Petros Pharmaceuticals, Inc. (PTPI).

Signal8 holds 3 ownership filings by Boctor Fady, all Form 4s, filed between Feb 21, 2025 and Jun 5, 2026. Those filings report 3 transactions, from Feb 19, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Boctor Fady's filings is in NEW YORK, NY.

Recent filings by Boctor Fady

  • Jun 5, 2026: Grant or award of PTPI shares (Form 4, code A).
  • Jan 2, 2026: Grant or award of PTPI shares (Form 4, code A).
  • Feb 19, 2025: Grant or award of PTPI shares (Form 4, code A).

Other insiders filing for Petros Pharmaceuticals, Inc. (PTPI)

How to read Form 4 transaction codes